{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:21:06Z","timestamp":1762431666549},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1097\/jcma.0000000000000043","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T04:30:19Z","timestamp":1560141019000},"page":"510-514","source":"Crossref","is-referenced-by-count":5,"title":["High level antibodies to TORCH in the IVIG preparation from Taiwanese"],"prefix":"10.1097","volume":"82","author":[{"given":"Ya-Ling","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kao-Hsian","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherng-Lih","family":"Perng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hueng-Chuen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Hsi","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyi-Jou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fung-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00001432-200206000-00014","article-title":"Sequelae of chorioamnionitis.","volume":"15","author":"Hagberg","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0095-5108(03)00110-6","article-title":"Infection as a cause of preterm birth.","volume":"30","author":"Goldenberg","year":"2003","journal-title":"Clin Perinatol"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clp.2014.11.001","article-title":"TORCH infections.","volume":"42","author":"Neu","year":"2015","journal-title":"Clin Perinatol"},{"key":"R4-14-20210129","first-page":"273","article-title":"TORCH infections in mothers as a cause of neonatal morbidity.","volume":"54","author":"MLadina","year":"2000","journal-title":"Med Arh"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.intimp.2005.11.003","article-title":"Differences between IGIV products: impact on clinical outcome.","volume":"6","author":"Gelfand","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jaci.2009.09.008","article-title":"Hepatitis A virus antibodies in immunoglobulin preparations.","volume":"125","author":"Farcet","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1423-0410.2002.00186.x","article-title":"A direct comparison of the antigen-specific antibody profiles of intravenous immunoglobulins derived from US and UK donor plasma.","volume":"83","author":"Matejtschuk","year":"2002","journal-title":"Vox Sang"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/519392","article-title":"West Nile virus neutralization by US plasma-derived immunoglobulin products.","volume":"196","author":"Planitzer","year":"2007","journal-title":"J Infect Dis"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4269\/ajtmh.14-0013","article-title":"Toxoplasma gondii seroprevalence in the United States 2009\u20132010 and comparison with the past two decades.","volume":"90","author":"Jones","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"e48139","DOI":"10.1371\/journal.pone.0048139","article-title":"Seroepidemiology of Toxoplasma gondii infection among healthy blood donors in Taiwan.","volume":"7","author":"Chiang","year":"2012","journal-title":"PLoS One"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: implications for control through routine immunization.","volume":"70","author":"Kilgore","year":"2003","journal-title":"J Med Virol"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhin.2011.11.011","article-title":"Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.","volume":"80","author":"Wu","year":"2012","journal-title":"J Hosp Infect"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2334-7-71","article-title":"Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.","volume":"7","author":"Colugnati","year":"2007","journal-title":"BMC Infect Dis"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1440-1754.2007.01215.x","article-title":"High perinatal seroprevalence of cytomegalovirus in northern Taiwan.","volume":"44","author":"Chen","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"R16-14-20210129","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/340041","article-title":"Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988\u20131994.","volume":"185","author":"Xu","year":"2002","journal-title":"J Infect Dis"},{"key":"R17-14-20210129","doi-asserted-by":"crossref","first-page":"e0134178","DOI":"10.1371\/journal.pone.0134178","article-title":"Seroprevalence of herpes simplex virus Type 1 and 2 in Taiwan and risk factor analysis, 2007.","volume":"10","author":"Shen","year":"2015","journal-title":"PLoS One"},{"key":"R18-14-20210129","first-page":"CD004226","article-title":"Antenatal interventions for fetomaternal alloimmune thrombocytopenia.","volume":"(5)","author":"Rayment","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1398-9995.2003.00239.x","article-title":"IVIG\u2013mechanisms of action.","volume":"58","author":"Simon","year":"2003","journal-title":"Allergy"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1085-5629(05)80016-1","article-title":"TORCH syndrome.","volume":"14","author":"Epps","year":"1995","journal-title":"Semin Dermatol"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3148.2002.00360.x","article-title":"In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations\u2013a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases.","volume":"12","author":"Krause","year":"2002","journal-title":"Transfus Med"},{"key":"R23-14-20210129","first-page":"29S","article-title":"Epidemiology of toxoplasmosis in Switzerland: national study of seroprevalence monitored in pregnant women 1990\u20131991.","volume":"65","author":"Jacquier","year":"1995","journal-title":"Schweiz Med Wochenschr Suppl"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.","volume":"39","author":"Pappas","year":"2009","journal-title":"Int J Parasitol"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0022-3476(89)80660-2","article-title":"Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.","volume":"115","author":"Hohlfeld","year":"1989","journal-title":"J Pediatr"},{"key":"R26-14-20210129","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2165\/00003495-198938060-00008","article-title":"Current recommendations and future prospects in the treatment of toxoplasmosis.","volume":"38","author":"McCabe","year":"1989","journal-title":"Drugs"},{"key":"R27-14-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/22.Supplement_B.193","article-title":"Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection.","volume":"22","author":"Couvreur","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"R28-14-20210129","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/bmj.318.7197.1511","article-title":"Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy","volume":"318","author":"Wallon","year":"1999","journal-title":"BMJ"},{"key":"R29-14-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.20913","article-title":"Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy.","volume":"53","author":"Mosca","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R30-14-20210129","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.jp.7200457","article-title":"The congenital varicella syndrome.","volume":"20","author":"Sauerbrei","year":"2000","journal-title":"J Perinatol"},{"key":"R31-14-20210129","first-page":"239","article-title":"Swiss recommendations for the management of varicella zoster virus infections.","volume":"137","author":"Kempf","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"R32-14-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00365540310000229","article-title":"Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study.","volume":"35","author":"Ratanajamit","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"R33-14-20210129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(89)90547-3","article-title":"Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.","volume":"2","author":"Miller","year":"1989","journal-title":"Lancet"},{"key":"R34-14-20210129","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2009-0047","article-title":"Varicella-specific immunoglobulin G titers in commercial intravenous immunoglobulin preparations.","volume":"124","author":"Maranich","year":"2009","journal-title":"Pediatrics"},{"key":"R35-14-20210129","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1097\/MPH.0b013e3181ec0efb","article-title":"Concomitant use of acyclovir and intravenous immunoglobulin rescues an immunocompromised child with disseminated varicella caused multiple organ failure.","volume":"33","author":"Lu","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R36-14-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.optm.2008.03.006","article-title":"Congenital rubella syndrome\u2013major review.","volume":"80","author":"Duszak","year":"2009","journal-title":"Optometry"},{"key":"R37-14-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MOP.0000000000000305","article-title":"Advances in the prevention and treatment of congenital cytomegalovirus infection.","volume":"28","author":"James","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"R38-14-20210129","first-page":"172","article-title":"Cytomegalovirus infection in pregnancy: should all women be screened?","volume":"3","author":"Carlson","year":"2010","journal-title":"Rev Obstet Gynecol"},{"key":"R39-14-20210129","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1311.061289","article-title":"Primary versus nonprimary cytomegalovirus infection during pregnancy, Israel.","volume":"13","author":"Rahav","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R40-14-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.diagmicrobio.2012.03.016","article-title":"Kinetics of CMV seroconversion in a Swiss pregnant women population.","volume":"73","author":"Maine","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R41-14-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1824-7288-40-23","article-title":"Epidemiology of Toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population.","volume":"40","author":"Puccio","year":"2014","journal-title":"Ital J Pediatr"},{"key":"R42-14-20210129","first-page":"53","article-title":"Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.","volume":"97","author":"Siadak","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"R43-14-20210129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.","volume":"323","author":"Sullivan","year":"1990","journal-title":"N Engl J Med"},{"key":"R44-14-20210129","first-page":"10","article-title":"Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients\u2013a meta-analysis.","volume":"8","author":"Glowacki","year":"1994","journal-title":"Clin Transplant"},{"key":"R45-14-20210129","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jcv.2009.08.017","article-title":"Findings and conclusions from CMV hyperimmune globulin treatment trials.","volume":"46","author":"Adler","year":"2009","journal-title":"J Clin Virol"},{"key":"R46-14-20210129","first-page":"946","article-title":"Increase in laboratory-confirmed cases of herpes genitalis and neonatal herpes infections in Israel.","volume":"19","author":"Leventon-Kriss","year":"1983","journal-title":"Isr J Med Sci"},{"key":"R47-14-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08923979509052718","article-title":"Intravenous immunoglobulins suppress the recurrences of genital herpes simplex virus: a clinical and immunological study.","volume":"17","author":"Masci","year":"1995","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R48-14-20210129","doi-asserted-by":"crossref","first-page":"e26469","DOI":"10.1371\/journal.pone.0026469","article-title":"A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms.","volume":"6","author":"Casulli","year":"2011","journal-title":"PLoS One"}],"container-title":["Journal of the Chinese Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCMA.0000000000000043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:33:54Z","timestamp":1620956034000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02118582-201906000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/jcma.0000000000000043","relation":{},"ISSN":["1726-4901"],"issn-type":[{"value":"1726-4901","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}